- Home
- TSBK vs IMMX Comparison
TSBK vs IMMX Comparison
Compare TSBK & IMMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TSBK | IMMX |
|---|---|---|
| Founded | 1915 | 2014 |
| Country | United States | United States |
| Employees | 280 | N/A |
| Industry | Banks | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 299.8M | 306.2M |
| IPO Year | 1997 | 2021 |
Fundamental Metrics
Financial Performance| Metric | TSBK | IMMX |
|---|---|---|
| Price | $37.85 | $9.70 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $16.33 |
| AVG Volume (30 Days) | 16.6K | ★ 630.8K |
| Earning Date | 04-21-2026 | 05-07-2026 |
| Dividend Yield | ★ 3.08% | N/A |
| EPS Growth | ★ 21.93 | 14.61 |
| EPS | ★ 1.04 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $36.24 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $27.51 | $1.34 |
| 52 Week High | $40.41 | $11.61 |
Technical Indicators
Market Signals| Indicator | TSBK | IMMX |
|---|---|---|
| Relative Strength Index (RSI) | 43.92 | 57.47 |
| Support Level | $37.56 | $1.96 |
| Resistance Level | $38.18 | N/A |
| Average True Range (ATR) | 0.81 | 0.78 |
| MACD | -0.14 | 0.03 |
| Stochastic Oscillator | 20.88 | 47.36 |
Price Performance
Historical ComparisonAbout TSBK Timberland Bancorp Inc.
Timberland Bancorp Inc is a bank holding company for Timberland Bank. The bank offers banking services including personal checking and savings accounts, debit cards, health savings accounts, online and mobile banking, online bill pay, 24-hour phone banking, and Zelle. Business services include business checking accounts, online banking, remote deposit, ACH transactions, Autobooks, and insured cash sweep services. The bank also provides lending services such as personal credit cards, home loans, home equity borrowing, construction loans, and SBA loans. In addition, it offers loans to real estate, including residential and commercial real estate, multi-family construction loans, one- to four-family residential loans, multi-family loans, commercial real estate loans, and land loans.
About IMMX Immix Biopharma Inc.
Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics TM in oncology and inflammation. Its TME Normalization Technology allows drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME. Its product candidates include CAR-T NXC-201 for autoimmune diseases, and IMX-110 for treatment of soft tissue sarcoma.